A leader of our Gamma Knife Center shares how this stereotactic radiosurgery technology has progressed over recent decades and where it may be headed next.
Combining stereotactic radiosurgery with an epidermal growth factor receptor-tyrosine kinase inhibitor may benefit patients with brain metastases from NSCLC but further study is needed to change standard of care.
New study evaluates the safety and efficacy of preoperative stereotactic radiosurgery.
Treatment goals in this setting are to extend survival, prevent neurological dysfunction and improve quality of life. Advances is surgical safety, stereotactic radiosurgery and systemic therapies have yielded mounting progress.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
From fractionated and volume-based staged radiosurgery strategies to use in combination with targeted immunotherapy, centers like Cleveland Clinic are finding new ways to make the most of this targeted stereotactic radiosurgery modality.
A prospective pilot study conducted in 16 patients with brain metastases found that 18F fluciclovine PET CT demonstrated promising utility in distinguishing radiation necrosis from tumor progression among patients treated with stereotactic radiosurgery.
In the latest Cancer Advances podcast, a veteran neurosurgeon profiles the enduring place of stereotactic radiosurgery in brain metastasis therapy and why most patients can be offered reassurance about prospects for metastasis control.
Outcomes correlate with the number of brain metastases primarily in patients without two actionable molecular targets: epidermal growth factor receptor mutations or anaplastic lymphoma kinase translocations.
The latest in our Neuro Pathways podcast series summarizes the heartening recent progress in surgical and medical treatment of this common malignancy.
Which research results from the American Society for Radiation Oncology’s 2019 annual meeting are the most interesting or clinically relevant? The staff of Cleveland Clinic Cancer Center’s Department of Radiation Oncology picks their Top 10.